Search

Your search keyword '"Bowles KR"' showing total 61 results

Search Constraints

Start Over You searched for: Author "Bowles KR" Remove constraint Author: "Bowles KR"
61 results on '"Bowles KR"'

Search Results

3. 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease and progressive supranuclear palsy converge on altered glial regulation

5. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults.

6. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction

7. Development of MAPT S305 mutation human iPSC lines exhibiting elevated 4R tau expression and functional alterations in neurons and astrocytes.

8. Novel avenues of tau research.

9. Improved Protocol for Reproducible Human Cortical Organoids Reveals Early Alterations in Metabolism with MAPT Mutations.

10. Development of MAPT S305 mutation models exhibiting elevated 4R tau expression, resulting in altered neuronal and astrocytic function.

11. A Mozambican marine protected area provides important habitat for vulnerable pelagic sharks.

12. Discordance between germline genetic findings and abnormal tumor immunohistochemistry staining of mismatch repair proteins in individuals with suspected Lynch syndrome.

13. The influence of 17q21.31 and APOE genetic ancestry on neurodegenerative disease risk.

14. 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson's disease are associated with LRRC37A/2 expression in astrocytes.

15. Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD.

16. Genome-wide association study and functional validation implicates JADE1 in tauopathy.

17. ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids.

18. Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response.

19. Impact of a Cancer Gene Variant Reclassification Program Over a 20-Year Period.

20. A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies.

21. Reduced variability of neural progenitor cells and improved purity of neuronal cultures using magnetic activated cell sorting.

22. Hereditary cancer testing challenges: assembling the analytical pieces to solve the patient clinical puzzle.

23. High-resolution temporal and regional mapping of MAPT expression and splicing in human brain development.

24. Complexities of Variant Classification in Clinical Hereditary Cancer Genetic Testing.

25. Identification of pathogenic retrotransposon insertions in cancer predisposition genes.

26. An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells.

28. Classification of genetic variants in genes associated with Lynch syndrome using a clinical history weighting algorithm.

29. Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD.

30. Exceptions to the rule: case studies in the prediction of pathogenicity for genetic variants in hereditary cancer genes.

31. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.

32. A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes.

33. Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genes.

34. Kinase signalling in Huntington's disease.

35. Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.

36. Gene expression and behaviour in mouse models of HD.

37. Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients.

38. Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients.

39. Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity.

40. Intrafamilial variability of noncompaction of the ventricular myocardium.

41. Viral genomic detection and outcome in myocarditis.

42. Genetics of inherited cardiomyopathies.

43. Isolated left ventricular noncompaction is rarely caused by mutations in G4.5, alpha-dystrobrevin and FK Binding Protein-12.

44. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction.

45. Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis.

46. Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction.

47. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome.

48. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy.

49. Construction of a high-resolution physical map of the chromosome 10q22-q23 dilated cardiomyopathy locus and analysis of candidate genes.

50. The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy.

Catalog

Books, media, physical & digital resources